| For: | Ge X, Luan X. Uncontrolled central hyperthermia by standard dose of bromocriptine: A case report. World J Clin Cases 2020; 8(23): 6158-6163 [PMID: 33344618 DOI: 10.12998/wjcc.v8.i23.6158] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v8/i23/6158.htm |
| Number | Citing Articles |
| 1 |
Maresa Santi, Samuel Ern Hung Tsan, Argyro Zoumprouli. Principles and Practice of Neurocritical Care. 2024; : 637 doi: 10.1007/978-981-99-8059-8_48
|
| 2 |
Min-Seok Woo, Seong-Hyun Park, Jeong-Hyun Hwang, Chaejin Lee. Management of posttraumatic refractory paroxysmal sympathetic hyperactivity with bromocriptine: a case report. Journal of Trauma and Injury 2026; 39(1): 68 doi: 10.20408/jti.2025.0016
|
| 3 |
Veronika Kissiová. Central neurogenic hyperthermia. Neurologie pro praxi 2023; 24(3): 212 doi: 10.36290/neu.2023.015
|
| 4 |
Valeria Perez, Morgan McCreary, Lyndsay Sheperd, Tanna Nelson, Kartavya Sharma. Antipyretic Efficacy of Bromocriptine in Central Fever: an Exploratory Analysis. Neurocritical Care 2023; 39(2): 499 doi: 10.1007/s12028-023-01703-7
|
| 5 |
|
| 6 |
Suneri J. Amin, Yasmin Aghajan, Andrew J. Webb. Clinical experience with bromocriptine for central hyperthermia after brain insult. Brain Injury 2024; 38(8): 652 doi: 10.1080/02699052.2024.2337231
|
| 7 |
Hayoung Choi, Ryeongtae Kim, Sooyoung Kim, Eunhee Sohn. Central Hyperthemia Treated with Bromocriptine in a Patient with Aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorder. Journal of Multiple Sclerosis and Neuroimmunology 2023; 14(2): 106 doi: 10.59578/jmsni.2023.14.2.106
|
